Centene (CNC) Stock Overview
Operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, and commercial organizations in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for CNC from our risk checks.
CNC Community Fair Values
Create NarrativeSee what 102 others think this stock is worth. Follow their fair value or set your own to get alerts.
Centene Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$35.37 |
| 52 Week High | US$66.81 |
| 52 Week Low | US$25.08 |
| Beta | 0.48 |
| 1 Month Change | -8.60% |
| 3 Month Change | 36.62% |
| 1 Year Change | -44.58% |
| 3 Year Change | -57.36% |
| 5 Year Change | -48.61% |
| Change since IPO | 2,367.67% |
Recent News & Updates
Recent updates
Centene: Strong Buy, For All The Wrong Reasons
Oct 21Centene Corporation's (NYSE:CNC) Price Is Right But Growth Is Lacking After Shares Rocket 30%
Sep 12
Why Investors Shouldn't Be Surprised By Centene Corporation's (NYSE:CNC) 38% Share Price Plunge
Jul 03
Centene (NYSE:CNC) Is Doing The Right Things To Multiply Its Share Price
May 15Centene Corporation's (NYSE:CNC) Low P/E No Reason For Excitement
Apr 03Centene: A Leader In Government-Sponsored Insurance And Its Prospects
Mar 26Centene Corporation Is Resilient And Will Thrive
Mar 18Centene's (NYSE:CNC) Returns On Capital Not Reflecting Well On The Business
Jan 27Centene: Attractive Risk-Reward For A Growing Company At A Value Price
Jan 02Does Centene (NYSE:CNC) Have A Healthy Balance Sheet?
Dec 05Centene: Should Have Followed My Original Thesis, But A Buy For Q3 2024
Oct 22Centene Corporation: Strategic Market Position Amid Favorable Trends, Buy
Aug 20Centene Corporation Still An Opportunity With An A-Grade Valuation
Mar 31Centene: Stay Defensive Amid Economic Uncertainty With This Low-Beta Bargain
Jan 22Centene: Overlooked Healthcare Giant
Nov 21Centene: Solid Performance With Positive Outlook, But Limited Upside Potential
Oct 26Shareholder Returns
| CNC | US Healthcare | US Market | |
|---|---|---|---|
| 7D | 6.7% | -6.4% | -0.2% |
| 1Y | -44.6% | -18.5% | 20.3% |
Return vs Industry: CNC underperformed the US Healthcare industry which returned -18.5% over the past year.
Return vs Market: CNC underperformed the US Market which returned 20.3% over the past year.
Price Volatility
| CNC volatility | |
|---|---|
| CNC Average Weekly Movement | 7.1% |
| Healthcare Industry Average Movement | 6.5% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in US Market | 17.4% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: CNC has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: CNC's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1984 | 60,500 | Sarah London | www.centene.com |
Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, and commercial organizations in the United States. The company operates through four segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment offers the temporary assistance for needy families; medicaid expansion; aged, blind, or disabled; and children's health insurance programs, as well as long-term services and supports; foster care; and medicare-medicaid plans.
Centene Corporation Fundamentals Summary
| CNC fundamental statistics | |
|---|---|
| Market cap | US$17.38b |
| Earnings (TTM) | -US$5.29b |
| Revenue (TTM) | US$167.68b |
Is CNC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CNC income statement (TTM) | |
|---|---|
| Revenue | US$167.68b |
| Cost of Revenue | US$148.02b |
| Gross Profit | US$19.66b |
| Other Expenses | US$24.95b |
| Earnings | -US$5.29b |
Last Reported Earnings
Sep 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -10.76 |
| Gross Margin | 11.72% |
| Net Profit Margin | -3.15% |
| Debt/Equity Ratio | 83.5% |
How did CNC perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/03 03:34 |
| End of Day Share Price | 2025/10/31 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Centene Corporation is covered by 37 analysts. 13 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| null null | Argus Research Company |
| Hua Ha | Baird |
| Joshua Raskin | Barclays |